Andrew Man-Lok Chan（陈文乐）

Prof., Chief

Cancer Biology and Experimental Therapeutics Theme, School of Biomedical Sciences, The Chinese University of Hong Kong

香港中文大学，医学院，生物医学学系

Office Addr.: Room 705, Lo Kwee-Seong Integrated Biomedical Sciences Building, Area 39, Shatin, New Territories, Hong Kong, China

Tel.:     (+852) 9343 3771

Fax:     (+852) 2603 5123

E-mail:  andrewmchan@cuhk.edu.hk

Webpage (URL):

http://www2.sbs.cuhk.edu.hk/en-gb/people/academic-staff/prof-chan-man-lok-andrew

Bibliography

Professor Andrew Chan obtained his Ph.D. degree in Molecular Biology from the Institute of Cancer Research at the Royal Marsden Hospital, University of London.  He was a Fogarty International Fellow at the National Cancer Institute of the United States National Institutes of Health, and Faculty Members at the Mount Sinai School of Medicine and the Medical College of Wisconsin. Professor Chan is currently a member of the Cancer Biology & Experimental Therapeutics Thematic Research Program. Professor Chan serves on multiple governmental granting agencies and has published 64 peer-reviewed papers with some in high impact journals such as Science, Nature Genetics, Cancer Cell, PNAS, Blood, and Nature Neuroscience. The laboratory of Professor Chan focuses on various cancer cell signaling pathways in the initiation and progression of human cancer. His research involves understanding the regulatory mechanisms of the PTEN tumor suppressor in brain cancer and neurodevelopmental disorders, as well as the Ras-related GTPase, R-Ras, in tumor immune microenvironment.